We found that dasatinib and saracatinib inhibited the migration of GC cells induced by co-culture with CAFs (Fig. 5A), while PDGFR and AKT inhibitors that could not inhibit CTGF induction showed marginal effects on the migration of GC cells (Supplementary Fig. 16). The gene discussed is AKT1; the disease is gastric cancer.